Curzio Research publishes market commentary for informational and educational purposes. The opinions expressed and market conditions when the content is published may change. It is not personalized investment advice or an offer to buy or sell securities. Investing involves risk, including possible loss of principal. Do your own research and consult a qualified investment professional before making investment decisions.
Interviews With Two of My Favorite Analysts
Today’s podcast begins with guest Marc Lichtenfeld, biotech analyst and editor of several newsletters at the Oxford Club. We discuss the latest JP Morgan Healthcare conference that he attended in San Francisco. He calls the conference the “Woodstock of Biotech” – since every important person in the biotech industry is usually in attendance.[app_audio src=”http://traffic.libsyn.com/sainvestorradio/WSU20EP20280.mp3″]
Marc has attended this conference for the past 7 years. He gives us the inside scoop on this year’s biggest themes in the industry, the important studies you need to know about, and what names should be on your watch list. He also shares his favorite biotech stocks to buy right now.
Then, Kristin Bentz, executive director of PMG Group and expert retail analyst, gives us a post-holiday update on retailers Wal-Mart, Coach, Gap, JC Penney and Lululemon. Kristin is a “boots on the ground” analyst who visits these stores and talks to executives in the industry on a monthly basis.
Kristin talks about which retail companies will benefit the most from lower oil prices. She also talks about the huge impact mobile phones are having on certain sales trends. Then, Kristin shares her favorite retailer stocks to buy heading into earnings season.
Have a question for Frank and Daniel,
submit it here: askcurzio.com
Follow Frank's
Wall Street Unplugged podcast
“I follow you. I’ve gotten amazing ideas for my shows from you.”
More Wall Street Unplugged
Investors are dumping CBRS—is it time to buy?
Is Cerebras (CBRS) a buy at its 52-week low? Plus, Meta's (META) Q3 earnings—and what its new share class means for investors… Why scaling is critical on both the upside and downside… And penny stock red flags to avoid.
This hyperscaler is a better buy than SPCX
Space Exploration Technologies' (SPCX) IPO—and the hyperscaler to buy instead. Plus, CoreWeave (CRWV) should be over $100… 2 AI stocks poised to double… Should you buy Netflix (NFLX) on this selloff? … And looking for dividends? Check this sector.
CoreWeave is in freefall—is it time to buy?
Is CoreWeave (CRWV) a buy amid its plunge? Plus, sectors to buy on the pullback… The telecom monopoly… Will the 10-year hit 6%? … Rate hikes for 2026… DigiPower X (DGXX) and VivoPower (VIVO)... And Berkshire's Lennar (LEN) move.
The big bank trade is over
The bull thesis around big banks has fallen apart. Plus, why good news isn't stopping the selloff… Are we in the middle of a bubble popping? … 3 sectors holding up amid the market carnage… And more.
The biggest winner of the GLP-1 trend
The winners and losers of the GLP-1 craze. Plus, what it takes to be a great stock analyst… Be cautious of this power stock—and one to buy instead… And why baseball sucks.
Did Google just revive the nuclear trade?
Will Alphabet's (GOOG) latest deal put a bottom under nuclear stocks? Plus, the Constellation Brands (STZ) CEO's crazy move… A few stocks are carrying the market… OpenAI's insane valuation… Is Disney (DIS) finally turning things around? … And more.
Latest episodes
